Regenerative Medical Technology Group annual net debt
2018
2019
2020
2022
2023
2024
2025
Regenerative Medical Technology Group Net Debt Growth & History (RMTG)
Regenerative Medical Technology Group's net debt was $1.8M for fiscal 2025.
View full Regenerative Medical Technology Group company overviewRegenerative Medical Technology Group annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.8M | $2.7M | — |
| 2024 | 2024-12-31 | −$847,426 | −$319,600 | — |
| 2023 | 2023-12-31 | −$527,826 | $1.1M | — |
| 2022 | 2022-12-31 | −$1.6M | — | — |
| 2020 | 2020-12-31 | $105,715 | −$1.1M | −91.55% |
| 2019 | 2019-12-31 | $1.3M | $469,587 | +60.05% |
| 2018 | 2018-12-31 | $781,993 | — | — |
Regenerative Medical Technology Group quarterly net debt
Q4.18
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.5M | $2.8M | — |
| Q1 2026 | 2026-03-31 | −$422,265 | $472,320 | — |
| Q4 2025 | 2025-12-31 | $1.8M | $2.7M | — |
| Q3 2025 | 2025-09-30 | −$598,769 | — | — |
| Q2 2025 | 2025-06-30 | −$1.3M | −$788,720 | — |
| Q1 2025 | 2025-03-31 | −$894,585 | −$440,237 | — |
| Q4 2024 | 2024-12-31 | −$847,426 | −$319,600 | — |
| Q2 2024 | 2024-06-30 | −$508,935 | $697,617 | — |
| Q1 2024 | 2024-03-31 | −$454,348 | $1.2M | — |
| Q4 2023 | 2023-12-31 | −$527,826 | $1.1M | — |
| Q3 2023 | 2023-09-30 | −$1.1M | $595,039 | — |
| Q2 2023 | 2023-06-30 | −$1.2M | $669,268 | — |
| Q1 2023 | 2023-03-31 | −$1.6M | $794,897 | — |
| Q4 2022 | 2022-12-31 | −$1.6M | — | — |
| Q3 2022 | 2022-09-30 | −$1.7M | — | — |
| Q2 2022 | 2022-06-30 | −$1.9M | $8.5M | — |
| Q1 2022 | 2022-03-31 | −$2.4M | −$1.8M | — |
| Q2 2021 | 2021-06-30 | −$10.3M | −$12.4M | — |
| Q1 2021 | 2021-03-31 | −$639,425 | −$2.3M | — |
| Q4 2020 | 2020-12-31 | $105,715 | −$1.1M | −91.55% |
| Q3 2020 | 2020-09-30 | $2.4M | — | — |
| Q2 2020 | 2020-06-30 | $2.0M | — | — |
| Q1 2020 | 2020-03-31 | $1.6M | — | — |
| Q4 2019 | 2019-12-31 | $1.3M | $469,587 | +60.05% |
| Q4 2018 | 2018-12-31 | $781,993 | — | — |
Regenerative Medical Technology Group net debt trends
Over the last five fiscal years, Regenerative Medical Technology Group's net debt increased from $105,715 to $1.8M, a change of $1.7M. The latest reported quarter, Q2 2026, shows $1.5M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regenerative Medical Technology Group source filings ↗